Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release added to pregabalin for painful diabetic polyneuropathy
2008-005815-17Phase 2Completed
- Sponsor
- Mundipharma Research
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing OXN PR + pregabalin with Placebo + pregabalin (2 arms). Primary endpoint: Short-Form McGill Pain Questionnaire. Started Jan 2009; status: completed.
02
Drugs
oxycodone + naloxonepregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2008-005815-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005815-17.